AAPL 205.29 +0.06 (+0.03%)MSFT 129.1 -0.05 (-0.04%)FB 193.17 +0.16 (+0.08%)ZNGA 5.47 +0.01 (+0.28%)NVDA 182 -5.01 (-2.68%)WBA 52.66 +0.01 (+0.02%)GOOG 1263.45 -0.18 (-0.01%)PIH 5.25 -0.05 (-0.94%)
AAPL 205.29 +0.06 (+0.03%)MSFT 129.1 -0.05 (-0.04%)FB 193.17 +0.16 (+0.08%)ZNGA 5.47 +0.01 (+0.28%)NVDA 182 -5.01 (-2.68%)WBA 52.66 +0.01 (+0.02%)GOOG 1263.45 -0.18 (-0.01%)PIH 5.25 -0.05 (-0.94%)

Balance Sheet ANAB Quote AnaptysBio

All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Year 201420152016
CashAndCashEqui 51 81 114
ShortTermInvest 0 167 313
Cash 51 248 427
AccountReceivab 1 2 0
Inventories 0 0 0
DeferredIncomeT 0 0 0
OtherCurrentAss 4 0 0
TotalCurrentAss 58 253 434
PPE 4 5 6
AccumulatedDepr -4 -4 -4
NetPPE 0 1 1
EquityAndOtherI 0 76 73
Goodwill 0 0 0
IntangibleAsset 0 0 0
OtherLTAssets 4 0 0
TotalNonCurrent 4 77 75
TotalAssets 62 329 509
ShortTermDebt 0 7 8
AccountsPayable 2 2 5
TaxesPayable 0 0 0
AccruedLiabilit 2 3 6
DeferredRevenue 0 0 0
OtherCurrentLia 1 2 2
TotalCurrentLia 6 14 22
Debt 14 8 1
DeferredTaxesLi 0 0 0
DeferredRevenue 0 0 0
OtherLTLiabilit 81 0 0
TotalNonCurrent 95 8 1
TotalLiabilitie 100 22 23
CommonStock 0 0 0
AdditionalPaidI 17 393 633
RetainedEarning -55 -85 -147
AccumulatedOthe -78 0 0
TotalStockholde -38 308 486
TotalLiabilitie 62 329 509
AnaptysBio Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes AnaptysBio Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.